Outside the Guidelines: Denosumab Overuse in Prostate Cancer – Medscape03/04/2024 majac Cancer Many men with castration-sensitive prostate cancer receive the bone-modifying agent to prevent skeletal-related events, but that practice is not …Share on FacebookTweetFollow usSave